viewG Medical Innovations Holdings Ltd

G Medical Innovations releases prospectus for NASDAQ listing after obtaining SEC approval

The public offering will be underwritten and solely managed by HC Wainwright & Co LLC.

G Medical specialises inmobile and e-health solutions using its suite of proprietary devices and software

G Medical Innovations Ltd (ASX:GMV) has made its prospectus for a public offering on the NASDAQ public after its registration was approved by the US Securities and Exchange Commission (SEC).

The company intends to list its American depositary shares on the capital market under the symbol GMVD and has proposed an equity capital raising to raise a minimum of US$17 million.

READ: G Medical Innovations signs key agreements with US health service providers

G Medical president & CEO Yacov Geva has also agreed to convert US$2 million of loan funds he advanced to the company into ordinary shares.

This comes soon after his recently approved loan conversion of US3,317,500 to ordinary shares at the April 24 company general meeting.

The company will remain on the ASX and be effectively dual listed on the NASDAQ after completing the public offering.

READ: G Medical Innovations advances mobile health technologies in March quarter

Executives from G Medical will embark on a US roadshow on June 3 after the mandatory exposure period closes.

The number of shares to be offered and sold, and the final amount proposed to be raised, will be finalised after the roadshow is complete.

A copy of the prospectus will be available on the company’s website and can be accessed on the SEC’s website.

Quick facts: G Medical Innovations Holdings Ltd

Price: 0.039 AUD

Market: ASX
Market Cap: $32.71 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...


Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 10/15/2018

2 min read